Brady W. Dougan, Director at Humacyte, Inc. (HUMA), sold 4,482,090 shares at $1.83 ($7.5M) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Open-market sale of $7.5M HUMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.83 | 549,360 | $1.0M | 13.5% |
| 2 | $1.83 | 549,360 | $1.0M | 13.5% |
| 3 | $1.63 | 1,100,000 | $1.8M | 24.0% |
| 4 | $1.63 | 1,100,000 | $1.8M | 24.0% |
| 5 | $1.58 | 591,685 | $935K | 12.5% |
| 6 | $1.58 | 591,685 |
| $935K |
| 12.5% |
| Total | $1.67 avg | 4,482,090 | $7.5M | 100% |
| Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |
| HUMA | SELL | 2024-08-29 | $11.4M | — | Filing → |